These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20518783)

  • 1. Clinical and genetic features of 20 Japanese patients with vascular-type Ehlers-Danlos syndrome.
    Shimaoka Y; Kosho T; Wataya-Kaneda M; Funakoshi M; Suzuki T; Hayashi S; Mitsuhashi Y; Isei T; Aoki Y; Yamazaki K; Ono M; Makino K; Tanaka T; Kunii E; Hatamochi A
    Br J Dermatol; 2010 Oct; 163(4):704-10. PubMed ID: 20518783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers-Danlos syndrome.
    Okita H; Ikeda Y; Mitsuhashi Y; Namikawa H; Kitamura Y; Hamasaki Y; Yamazaki S; Hatamochi A
    Arch Dermatol Res; 2010 Jul; 302(5):395-9. PubMed ID: 19543901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of vascular Ehlers-Danlos syndrome in Italy: clinical findings and novel COL3A1 mutations.
    Drera B; Zoppi N; Ritelli M; Tadini G; Venturini M; Wischmeijer A; Nicolazzi MA; Musumeci A; Penco S; Buscemi L; Crivelli S; Danesino C; Clementi M; Calzavara-Pinton P; Viglio S; Valli M; Barlati S; Colombi M
    J Dermatol Sci; 2011 Dec; 64(3):237-40. PubMed ID: 22019127
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel mutation screening system for Ehlers-Danlos Syndrome, vascular type by high-resolution melting curve analysis in combination with small amplicon genotyping using genomic DNA.
    Naing BT; Watanabe A; Shimada T
    Biochem Biophys Res Commun; 2011 Feb; 405(3):368-72. PubMed ID: 21219851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
    Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
    Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
    Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
    PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel point mutation in type III collagen gene resulting in exon 24 skipping in a case of vascular type Ehlers-Danlos syndrome.
    Okamoto O; Ando T; Watanabe A; Sato F; Mimata H; Shimada T; Fujiwara S
    Arch Dermatol Res; 2008 Oct; 300(9):525-9. PubMed ID: 18779970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic analysis in the clinical diagnosis of Ehlers-Danlos syndrome type IV].
    Chen B; Guan YQ; Wu XL; Qi YX; Yu HX; Li JX; Zhang J
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1122-4. PubMed ID: 21609597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications.
    Beridze N; Frishman WH
    Cardiol Rev; 2012; 20(1):4-7. PubMed ID: 22143279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Ehlers-Danlos syndrome: a case with fatal outcome.
    Morais P; Mota A; Eloy C; Lopes JM; Torres F; Palmeiro A; Tavares P; Azevedo F
    Dermatol Online J; 2011 Apr; 17(4):1. PubMed ID: 21549076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of 11 new mutations in COL3A1 of individuals with Ehlers-Danlos syndrome type IV: preliminary comparison of RNase cleavage, EMC and DHPLC assays.
    Giunta C; Steinmann B
    Hum Mutat; 2000 Aug; 16(2):176-7. PubMed ID: 10923041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.
    Watanabe A; Kosho T; Wada T; Sakai N; Fujimoto M; Fukushima Y; Shimada T
    Circ J; 2007 Feb; 71(2):261-5. PubMed ID: 17251678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New COL3A1 Mutation in Ehlers-Danlos Syndrome Vascular Type With Different Phenotypes in the Same Family.
    Cortini F; Marinelli B; Romi S; Seresini A; Pesatori AC; Seia M; Montano N; Bassotti A
    Vasc Endovascular Surg; 2017 Apr; 51(3):141-145. PubMed ID: 28183226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
    Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
    N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
    Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
    Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.
    Shalhub S; Byers PH; Hicks KL; Coleman DM; Davis FM; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Charlton-Ouw K; Behrendt CA; Debus ES; von Kodolitsch Y; Zarkowsky D; Powell RJ; Pepin M; Milewicz DM; Regalado ES; Lawrence PF; Woo K
    J Vasc Surg; 2020 Jan; 71(1):149-157. PubMed ID: 31353273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular Ehlers-Danlos syndromes--biochemical and molecular-genetic investigations].
    Lund AM
    Ugeskr Laeger; 2006 Feb; 168(9):915-20. PubMed ID: 16513057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.